LEADER 01355nam  2200385Ia 450 
001 9910696977803321
005 20230902161849.0
035   $a(CKB)5470000002383111
035   $a(OCoLC)535501726
035   $a(EXLCZ)995470000002383111
100   $a20100302d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aReviewer guidance$b[electronic resource] $eintegration of study results to assess concerns about human reproductive and developmental toxicities
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2001]
215   $a1 electronic resource (26 pages) $ccharts
300   $a"Draft guidance."
300   $a"October 2001."
517   $aReviewer guidance 
606   $aReproductive toxicology$zUnited States
606   $aDevelopmental toxicology$zUnited States
606   $aDrugs$zUnited States$xTesting
615  0$aReproductive toxicology
615  0$aDevelopmental toxicology
615  0$aDrugs$xTesting.
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696977803321
996   $aReviewer guidance$93514523
997   $aUNINA